Analysis of the clinical characteristics and prognostic factors of 19 primary nodal peripheral T-cell lymphoma
- Author:
- No author available
- Journal Title:
- JOURNAL OF LEUKEMIA & LYMPHOMA
- Issue:
- 4
- DOI:
- 10.3760/cma.j.issn.1009-9921.2011.04.006
- Key Word:
- 淋巴瘤,T细胞,外周;预后因素;Lymphoma,T-cell,peripheral;Prognostic factor
Abstract： Objective To investigate the clinical characteristics, therapeutic outcomes and prognostic factors of primary nodal peripheral T-cell lymphoma(PTCL). Methods Clinical records, therapy responses as well as prognostic factors of 19 PTCL patients were analyzed. Results The median age of the 19 patients was Ⅲ-Ⅳ, 84.2 % (16/19) with B symptoms, 84.2 % (16/19) with extranodal involvement, 57.9 % (11/19) with bone marrow involvement. After treatment, the complete remission (CR) rate was 36.8 % (7/19). The 2-year overall survival (OS) rate of all patients was 47.2 % and the 2-year progression free survival (PFS) rate was 25 %. The number of sites of extranodal involvement (EN)≥2, ECOG≥2, IPI＞2 and elevated β2-MG were poor prognostic factors. Conclusion Primary nodal PTCL is a heterogeneous group of aggressive T-cell lymphoma with poor chemotherapy results. Multifactors indicate negative prognosis.
- [1]John P, Greer.Therapy of peripheral T/NK neoplasms.[J].2006.
- [2]R D, Gascoyne,P, Aoun,D, Wu,etc.Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.[J].1999,93.
- [3]Moles MP,Mohty M,Le-Gouill S,etc.Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire.[J].2008,26(14).
- [4]B, Falini,S, Pileri,P L, Zinzani,etc.ALK+ lymphoma: clinico-pathological findings and outcome.[J].1999,93.
- [5]Cheson BD,Connors JM,Cabanillas F,etc.Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas.[J].1999,17(4).
- [6]Sohn BS,Kim EK,Park I.Comparison of clinical outcome after autologous stem cell transplantation between patients with peripheral T-cell lymphomas and diffuse large B-cell lymphoma.[J].2009,44(5).
- [7]Armitage J,Vose J,Weisenburger D.International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.[J].2008,26(25).
- [8]O'leary H,Savage KJ.The spectrum of peripheral T-cell lymphomas.[J].2009,16(4).